Church of Scientology Celebrates “Freedom of Religion” for all Faiths

Jul 27, 2017 00:30 am UTC| Business

CLEARWATER, Fla., July 26, 2017 -- On July 22nd the Scientology Choir, guest singers and members of the local community came together in support of freedom of religion at the Scientology Information Center in Downtown...

Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended release), an Abuse-Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain

Jul 27, 2017 00:15 am UTC| Business

TORONTO, July 26, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...

Xenith Bankshares, Inc. Reports Second Quarter and First Half 2017 Results

Jul 27, 2017 00:08 am UTC| Business

RICHMOND, Va., July 26, 2017 -- Xenith Bankshares, Inc. (Nasdaq:XBKS), parent company of Xenith Bank, announced financial results for the three and six months ended June 30, 2017. The company reported net income of...

Pulse Seismic Inc. Reports Q2 2017 Results

Jul 27, 2017 00:07 am UTC| Business

CALGARY, Alberta, July 26, 2017 -- Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or “the Company”) is pleased to report its financial and operating results for the three and six months ended June 30, 2017. The...

ATX Seed Ventures Awarded 2017 INNOVATION Award by China-US Chamber of Commerce

Jul 26, 2017 23:47 pm UTC| Business

NEW YORK, July 26, 2017 -- ATX Seed Ventures (www.atxseedventures.com), a Texas early stage venture capital firm, announces it received the 2017 INNOVATION Award by the China-US Chamber of Commerce (www.cnusa.org). The...

Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock

Jul 26, 2017 23:30 pm UTC| Business

WESTLAKE VILLAGE, Calif., July 26, 2017 -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced the pricing of the Company’s initial public offering of 4,333,333 shares of common stock at a public offering...

Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Public Offering

Jul 26, 2017 23:18 pm UTC| Business

IRVING, Texas, July 26, 2017 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of...